From professional translators, enterprises, web pages and freely available translation repositories.
treatment regimens in study n016966 (mcrc)
ensayo no16966 (ccrm)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
metastatic carcinoma of the colon or rectum (mcrc)
carcinoma metastásico de colon o recto (ccrm)
Last Update: 2017-04-26
Usage Frequency: 7
Quality:
pres was not reported in the pivotal phase iii study of mcrc patients.
en el estudio pivotal fase iii de pacientes con ccrm no se notificó sepr.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
treatment regimens in study no16966 (mcrc) treatment starting dose
regímenes de tratamiento en el ensayo no16966 (ccrm) tratamiento dosis inicial 2
Last Update: 2012-04-10
Usage Frequency: 4
Quality:
treatment regimens in study no16966 (mcrc) treatment starting dose 2
folfox-4regímenes de tratamiento tratamiento 85 oxaliplatino
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
the safety of vectibix in patients with mcrc who received at least one dose of vectibix was evaluated in 920 patients.
se evaluó la seguridad de vectibix en 920 pacientes con ccrm que recibieron al menos una dosis de vectibix.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
results in patients with wild-type ras mcrc and mutant ras mcrc are presented in the table below.
en la tabla de abajo se presentan los resultados en pacientes con ccrm con ras no mutado y ras
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
efficacy results in patients with wild-type ras mcrc and mutant ras mcrc are shown in the below table.
en la tabla siguiente se incluyen los resultados de eficacia en pacientes con ccrm con ras no mutado y ccrm ras mutado.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
montagnani et al used the results from the above three studies to provide an overall analysis of randomised studies comparing folfiri and xeliri treatment regimens in the treatment of mcrc.
monatgnani et al. utilizaron los resultados de los tres estudios anteriores para ofrecer un análisis global de los estudios aleatorizados comparando las pautas de folfiri y las de xeliri en el tratamiento del cáncer colorrectal metastásico.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
not reported in mcrc study; however, pres was reported in patients from other studies treated with aflibercept as monotherapy and in combination with chemotherapies other than folfiri
no notificados en estudios de ccrm; sin embargo se ha notificado sepr en pacientes de otros estudios tratados con aflibercept en monoterapia y en combinación con otras quimioterapias diferentes a folfiri
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
for patients with ecog 2 performance status, assessment of benefit-risk is recommended prior to initiation of vectibix in combination with chemotherapy for treatment of mcrc.
en los pacientes con un estado funcional ecog 2, se recomienda evaluar el beneficio-riesgo antes de iniciar el tratamiento con vectibix en combinación con quimioterapia para el tratamiento del ccrm.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
additional studies were performed with vectibix as a single agent in patients with other solid tumours and in combination with chemotherapy with and without bevacizumab in patients with mcrc or in combination with chemotherapy in patients with non-small cell lung cancer.
se realizaron ensayos adicionales con vectibix en monoterapia en pacientes con otros tumores sólidos y en combinación con quimioterapia con o sin bevacizumab en pacientes con ccrm o en combinación con quimioterapia en pacientes con cáncer de pulmón no microcítico.
Last Update: 2012-04-10
Usage Frequency: 3
Quality: